Phase II Study of Herzuma® Plus Gedatolisib in Patients With HER-2 Positive Metastatic Breast Cancer
Clinical trial NCT03698383 · UNKNOWN
Trial details
- NCT number
- NCT03698383
- Sponsor
- Korean Cancer Study Group
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-03
- Primary completion
- 2021-10-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.